STRYKER CORP (SYK) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 14.19B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | 250.00M USD | Commercial Paper |
| Cash and current securities | 3.48B USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities · Commercial Paper |
| Total assets | 47.93B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $14.19B | $250.00M | $3.48B | $47.93B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $14.22B | (m) | $2.96B | $46.29B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $14.86B | $0.00 | $4.10B | $47.84B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $14.85B | $0.00 | $3.34B | $47.06B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $14.83B | $0.00 | $2.46B | $46.33B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $14.38B | $0.00 | $2.41B | $46.01B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $12.19B | $0.00 | $3.74B | $42.97B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $13.32B | $0.00 | $3.93B | $43.83B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $10.13B | $0.00 | $1.96B | $39.13B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $10.81B | $0.00 | $2.41B | $39.40B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $10.90B | $0.00 | $3.05B | $39.91B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $10.38B | $0.00 | $1.94B | $38.04B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $11.15B | $0.00 | $1.48B | $37.41B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $11.86B | $0.00 | $1.76B | $36.83B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $11.86B | $0.00 | $1.93B | $36.88B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $12.75B | $0.00 | $1.50B | $35.98B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $13.37B | $0.00 | $1.13B | $36.03B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $13.88B | $195.00M | $1.53B | $36.14B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $12.47B | $0.00 | $3.02B | $34.63B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $12.63B | $0.00 | $2.64B | $34.15B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $12.73B | $0.00 | $2.33B | $33.70B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $13.06B | $0.00 | $2.31B | $33.45B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $13.23B | $0.00 | $3.02B | $34.33B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $12.01B | $0.00 | $7.16B | $32.29B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $11.81B | $0.00 | $6.62B | $31.48B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $9.40B | $0.00 | $4.05B | $29.44B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $10.23B | $0.00 | $4.42B | $30.17B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $7.89B | $0.00 | $2.04B | $26.66B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $7.97B | $0.00 | $1.84B | $26.35B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $7.95B | $0.00 | $1.76B | $25.94B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $8.49B | $0.00 | $3.70B | $27.23B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $5.93B | $0.00 | $2.21B | $22.08B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $5.92B | (m) | $1.92B | $21.57B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $5.92B | $100.00M | $2.46B | $22.13B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $6.59B | $0.00 | $2.79B | $22.20B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $6.59B | $0.00 | $2.69B | $21.48B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $6.59B | $120.00M | $3.75B | $21.29B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $7.18B | $0.00 | $3.28B | $20.52B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $6.69B | $200.00M | $3.38B | $20.43B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $6.71B | $100.00M | $3.02B | $20.19B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $6.72B | $145.00M | $3.66B | $20.52B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $6.71B | (m) | $7.48B | $19.67B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $3.25B | (m) | $4.08B | $16.25B | (m) |
| 2015-09-30 | (m) | (m) | (m) | $2.51B | (m) | $3.37B | $15.92B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $3.24B | (m) | $4.28B | $16.82B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $3.26B | (m) | $4.26B | $16.58B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $3.25B | (m) | $5.00B | $17.71B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $3.23B | (m) | $4.68B | $17.52B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $3.24B | $500.00M | $4.75B | $17.23B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $2.24B | $500.00M | $4.05B | $16.16B | (m) |
| 2013-12-31 | (m) | (m) | (m) | $2.74B | (m) | $3.98B | $15.74B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $2.74B | (m) | $5.14B | $14.88B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $2.74B | (m) | $4.65B | $14.38B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $2.74B | (m) | $4.49B | $14.09B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $1.75B | (m) | $4.29B | $13.21B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $1.75B | (m) | $3.86B | $12.78B | (m) |
| 2012-06-30 | (m) | (m) | (m) | $1.75B | (m) | $3.46B | $12.26B | (m) |
| 2012-03-31 | (m) | (m) | (m) | $1.75B | (m) | $3.30B | $12.46B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $1.75B | $500.00M | $3.42B | $12.40B | (m) |
| 2011-09-30 | (m) | (m) | (m) | $1.75B | $500.00M | $3.21B | $12.08B | (m) |
| 2011-07-15 | (m) | (m) | (m) | (m) | $500.00M | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | $996.70M | (m) | $2.67B | $11.60B | (m) |
| 2011-03-31 | (m) | (m) | (m) | $996.60M | (m) | $2.89B | $11.23B | (m) |
| 2010-12-31 | (m) | (m) | (m) | $996.50M | (m) | $4.38B | $10.90B | (m) |
| 2010-09-30 | (m) | (m) | (m) | $996.40M | (m) | $4.51B | $10.77B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $996.30M | (m) | $4.03B | $10.06B | (m) |
| 2010-03-31 | (m) | (m) | (m) | $996.20M | (m) | $3.94B | $10.10B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |